Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.64 USD -2.94% Market Closed
Market Cap: 777.9m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Long-Term Debt Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Long-Term Debt
CA$500k
CAGR 3-Years
-47%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Long-Term Debt
CA$41k
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Long-Term Debt
CA$100k
CAGR 3-Years
71%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Abcellera Biologics Inc's Long-Term Debt?
Long-Term Debt
0 USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Long-Term Debt amounts to 0 USD.

Back to Top